The ACC/AHA/Physician Consortium Atrial Fibrillation or Atrial Flutter Performance
Measures Writing Committee (the Writing Committee) was charged to develop performance …

In the summer of 2015, the ACC/AHA convened the writing committee to begin the process
of revising the existing atrial fibrillation (AF) and atrial flutter measure set that was released …

1.1. Background In 2020, the Task Force convened the writing committee to begin the
process of updating the atrial fibrillation measure on chronic anticoagulation therapy from …

Background—Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It is a
cause of stroke, heart failure, and death. Guideline-based treatment can improve outcomes …

Background The severity of symptoms caused by atrial fibrillation (AF) is extremely variable.
Quantifying the effect of AF on patient well-being is important but there is no simple …

Background In patients with atrial fibrillation (AF), adherence to guidelines for antithrombotic
treatment is poorly followed, and undertreatment (or nonadherence with guidelines) is …

Aims As health systems around the world increasingly look to measure and improve the
value of care that they provide to patients, being able to measure the outcomes that matter …

Atrial fibrillation (AF) is the most common arrhythmia and is associated with increased risks
of stroke, heart failure, dementia, and death. 1–8 Because the number of elderly individuals …

Importance Current guidelines support treating atrial fibrillation (AF) and atrial flutter (AFL)
as equivalent risk factors for ischemic stroke stratified by CHA 2 DS 2-VASc scores …

Background: The Atrial Fibrillation Effect on Quality-of-Life (AFEQT) questionnaire has
recently been validated to measure the impact of atrial fibrillation on quality of life, but a …